PharmaVOICE
PharmaLinx’s core product is
PharmaVOICE magazine, which
was launched to the life-sciences
industry in July 2001.
PharmaVOICE magazine is the
monthly executive forum that
allows business leaders to
engage in a candid dialogue on
myriad challenges and trends
that impact the life-sciences
industry. PharmaVOICE’s forums,
topics, and feature articles
present provoking commentary
through a multiple-perspective
format.
Since its launch with an initial
circulation of 10,000,
PharmaVOICE has increased its
circulation to more than 17,500
executives throughout the life-sciences
industry. These leaders
rely on PharmaVOICE as a“must-read” for peer-to-peer
insights on a broad range of
business practices and topics.
Since the first issue, the
response to the magazine has
been overwhelming — industry
executives state that
PharmaVOICE fills a void in the
industry and call the publication
excellent, readable, and fresh.
Having successfully
published eight issues of
PharmaVOICE in 2002,
PharmaLinx increased the
publication’s frequency to 10 times a year.
The increase in frequency allows
PharmaVOICE’s editors the
opportunity to reach out to more
thought leaders for its in-depth
original forums, feature articles, topics, and departments. |
 |
PharmaVOICE engages an
average of 75 top-level decision
makers from diverse industry
sectors to facilitate and improve
business-to-business, department-to-
department, and colleague-to-colleague
relationships.
PharmaVOICE’s editorial mission
is to provide actionable insights on
the issues of today and identify
the trends that will help executives
shape the industry’s future — “Your Agenda is Our Agenda!”
More About PharmaVOICE 
VIEWs
More than a directory of
companies and services — these
one-of-a-kind publications provide
individual editorial opportunities
for executives in a specific
industry arena to raise their
VOICE on the evolving trends and
regulations that are impacting the
future of dynamic and important
sectors. In addition to contributed
insider VIEWs, original editorial
content includes the Forum, which
presents the insights of executives
involved in the specific life-sciences
sector. The VIEWs are
distributed to the PharmaVOICE
reader base of more than 17,500
U.S.-based subscribers as well as
at pertinent industry events and
conferences.
More About VIEWs |
